Tuning the cytotoxicity of ruthenium(II) para-cymene complexes by mono-substitution at a triphenylphosphine/phenoxydiphenylphosphine ligand

被引:51
作者
Biancalana, Lorenzo [1 ]
Zacchini, Stefano [2 ]
Ferri, Nicola [3 ]
Lupo, Maria Giovanna [3 ]
Pampaloni, Guido [1 ]
Marchetti, Fabio [1 ]
机构
[1] Univ Pisa, Dipartimento Chim & Chim Ind, Via G Moruzzi 13, I-56124 Pisa, Italy
[2] Univ Bologna, Dipartimento Chim Ind Toso Montanari, Viale Risorgimento 4, I-40136 Bologna, Italy
[3] Univ Padua, Dipartimento Sci Farmaco, Via Marzolo 5, I-35131 Padua, Italy
关键词
VITRO ANTICANCER ACTIVITY; ARENE COMPLEXES; ANTIPROLIFERATIVE ACTIVITY; CONDUCTIVITY MEASUREMENTS; COORDINATION CHEMISTRY; ANTITUMOR-ACTIVITY; DRUGS; DICHLOROACETATE; DEHYDROGENATION; HYDROGENATION;
D O I
10.1039/c7dt03385k
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The new complexes [RuCl2(eta(6)-p-cymene)(kappa P-Ph2PR)] [R = 4-C6H4OSiMe2 Bu-t, 1; R = 4-C6H4Br, 2; R = OC(=O) CHCl2, 3; R = OPh, 4; R = O(2-C6H4SiMe2 tBu), 5] and [Ru(C2O4)(eta(6)-p-cymene){kappa P-Ph2PO(2-C6H4(SiMe(2)tBu))}], 6, were obtained in 83-98% yield from Ru(II) arene precursors by three different synthetic strategies. The unprecedented phosphine Ph2P(O(2-C6H4SiMe2 Bu-t)) was synthesized in 86% yield from 2-C6H4Br((OSiMe2Bu)-Bu-t) and Ph2PCl, via intramolecular oxygen to carbon 1,3 migration of the silyl group (retro-Brook rearrangement). All the complexes were fully characterized by analytical and spectroscopic methods, and by single crystal X-ray diffraction in the cases of 3, 4, 5 and 6. Complexes 1-6 and the model compounds [RuCl2(eta(6)-p-cymene)(kappa P-PPh3)] (Ru-PPh3) and [Ru(C2O4)(eta(6)-p-cymene)(kappa P-PPh3)] (Ru-PPh3-O) underwent slow degradation in chloroform solutions upon air contact; the mixed valence complex [(eta(6)-p-cymene) Ru(mu-Cl)(3)RuCl2(kappa P-PPh3)], 7, was isolated from a solution of Ru-PPh3 in CHCl3, and X-ray identified. The antiproliferative activity of 1-6 and Ru-PPh3, Ru-PPh3-O and [RuCl2(eta(6)-pcymene)(.P-PTA)] (RAPTA-C) was assessed towards the triple-negative breast cancer cell line MDA-MB-231, the ovarian carcinoma cell line A2780 and human skin fibroblasts (HSF). Complexes 1, 2, 5 and 6 displayed IC50 values significantly lower than that of cisplatin, with 2 providing a more potent cytotoxic effect on MDA-MB-231 and A2780 cancer cells compared to the noncancerous cell line (HSF). The stability of all complexes in DMSO/water solution was elucidated by NMR and conductivity measurements, and in particular Cl-35 NMR spectroscopy was helpful to check the possible chloride dissociation. The stability studies suggest that the cytotoxic activity in vitro of the compounds is mainly ascribable to Ru(II) species still bound to the phosphorus ligand.
引用
收藏
页码:16589 / 16604
页数:16
相关论文
共 101 条
[1]   Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity [J].
Adhireksan, Zenita ;
Davey, Gabriela E. ;
Campomanes, Pablo ;
Groessl, Michael ;
Clavel, Catherine M. ;
Yu, Haojie ;
Nazarov, Alexey A. ;
Yeo, Charmian Hui Fang ;
Ang, Wee Han ;
Droege, Peter ;
Rothlisberger, Ursula ;
Dyson, Paul J. ;
Davey, Curt A. .
NATURE COMMUNICATIONS, 2014, 5
[2]   Synthesis and Antiproliferative Activity of New Ruthenium Complexes with Ethacrynic-Acid-Modified Pyridine and Triphenylphosphine Ligands [J].
Agonigi, Gabriele ;
Riedel, Tina ;
Zacchini, Stefano ;
Paunescu, Emilia ;
Pampaloni, Guido ;
Bartalucci, Niccolo ;
Dyson, Paul J. ;
Marchetti, Fabio .
INORGANIC CHEMISTRY, 2015, 54 (13) :6504-6512
[3]   Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective [J].
Alessio, Enzo .
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2017, (12) :1549-1560
[4]   Preparation of new half sandwich ruthenium arene complexes with aminophosphines as potential chemotherapeutics [J].
Aliende, Cristina ;
Perez-Manrique, Mercedes ;
Jalon, Felix A. ;
Manzano, Blanca R. ;
Rodriguez, Ana M. ;
Vicente Cuevas, Jose ;
Espino, Gustavo ;
Angeles Martinez, Ma ;
Massaguer, Anna ;
Gonzalez-Bartulos, Marta ;
de Llorens, Rafael ;
Moreno, Virtudes .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2012, 117 :171-188
[5]   Metal-based drugs that break the rules [J].
Allardyce, Claire S. ;
Dyson, Paul J. .
DALTON TRANSACTIONS, 2016, 45 (08) :3201-3209
[6]   [Ru(η6-p-cymene)Cl2(pta)] (pta=1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane):: a water soluble compound that exhibits pH dependent DNA binding providing selectivity for diseased cells [J].
Allardyce, CS ;
Dyson, PJ ;
Ellis, DJ ;
Heath, SL .
CHEMICAL COMMUNICATIONS, 2001, (15) :1396-1397
[7]   Novel pyrazolylphosphite- and pyrazolylphosphinite-ruthenium(II) complexes as catalysts for hydrogenation of acetophenone [J].
Amenuvor, Gershon ;
Obuah, Collins ;
Nordlander, Ebbe ;
Darkwa, James .
DALTON TRANSACTIONS, 2016, 45 (34) :13514-13524
[8]   Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis [J].
Ang, Wee Han ;
Daldini, Elisa ;
Scolaro, Claudine ;
Scopelliti, Rosario ;
Juillerat-Jeannerat, Lucienne ;
Dyson, Paul J. .
INORGANIC CHEMISTRY, 2006, 45 (22) :9006-9013
[9]  
[Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
[10]   [RuCl2(η6-p-cymene)(P*)] and [RuCl2(κ-P*-η6-arene)] Complexes Containing P-Stereogenic Phosphines. Activity in Transfer Hydrogenation and Interactions with DNA [J].
Aznar, Rosario ;
Grabulosa, Arnald ;
Mannu, Alberto ;
Muller, Guillermo ;
Sainz, Daniel ;
Moreno, Virtudes ;
Font-Bardia, Merce ;
Calvet, Teresa ;
Lorenzo, Julia .
ORGANOMETALLICS, 2013, 32 (08) :2344-2362